Methode Electronics, Inc.
MEIMethode Electronics, Inc. is coiled. The quarters are improving, yet the P/E sits at the 15th percentile of its own 2-year range — the business is moving before the market.
Biggest watch item: the price is already 9 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (9 weeks in) while the P/E sits at the 15th percentile of its own 2-year range. Underneath, the last four quarters read improving, and 128% of the last 2 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Methode Electronics, Inc. trades at $15.1, in a confirmed uptrend and 9 weeks into that stage. That is +65.0% against its own 200-day average. It sits at 71% of a 52-week range of $5 to $19. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 13 straight weeks.
Today the stock is in a confirmed uptrend — week 9 of stage 2. At $15.1 it trades +65.0% versus its 200-day average and sits at 71% of its 52-week range ($5–$19).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved −56% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 13 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Methode Electronics, Inc. trades at 14.1× P/E, near the bottom of its own range — cheaper only 15% of the time. Its long-run median P/E is 16.1×, measured across 1.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 14.1× is near the bottom of its own range — cheaper only 15% of the time, against a long-run median of 16.1× measured over 1.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Methode Electronics, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −2.9% | −4.7% | — | — |
| Stock price | +138.5% | −23.2% | −20.7% | −8.2% |
4-Factor Sector Score
55.2/100 — rank 4 of 30 in Electronic Components · 64% evidence confidence
Methode Electronics, Inc. scores 55.2 out of 100 against the 30 companies it is compared with in Electronic Components, ranking 4. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19 + 5.2 + 11.2 + 19.8 = 55.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Methode Electronics, Inc. reported $0.3 B of revenue in the May 26 quarter, +15.4% year on year. Over 4 years it has compounded at −3.2% a year. The last full year, FY26, came in at $1.0 B. The last four reported quarters add to $1.0 B.
FY26 revenue came in at $1.0 B (−2.9% on the year), capping 4 years at −3.2% compound. The latest quarter (May 26) printed $0.3 B, +15.4% year on year.
Pace check: the last four quarters averaged −2.6% growth against the decade's −3.2% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −2.9% over the last 4 quarters against −4.6%/yr over the last 8 — stabilising.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Methode Electronics, Inc.'s operating margin is 3.3% in the May 26 quarter, +11.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −9.9% to 9.5%. The current quarter sits inside that band.
The latest quarter's operating margin is 3.3%, +11.0 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −9.9%–9.5%.
Why the margin moved: operating margin went +11.0 pp year on year while gross margin went +15.6 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Methode Electronics, Inc. earned $0.0 B of net profit in the May 26 quarter. The full FY26 year was a loss of $0.04 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier lost $0.03 B. 9 of the last 12 reported quarters were loss-making.
May 26 profit was $0.0 B, null year on year. On the full year, FY26 printed $−0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 2 fiscal years 128% of Methode Electronics, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $0.0 B of operating cash against $−0.0 B of profit. After $0.0 B of capital spending, $0.0 B was left as free cash.
FY26: operating cash of $0.0 B against reported profit of $−0.0 B, leaving free cash of $0.0 B after $0.0 B of capital spending. Across the last 2 fiscal years the conversion rate is 128% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Methode Electronics, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Methode Electronics, Inc. earns a ROE of −6% in FY26. That is up from a trough of −16% in FY24. Return on invested capital clears the cost of that capital by −8.0 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −3.9% net margin on 0.78× asset turns.
FY26 ROE is −6%, recovered from a FY24 trough of −16% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): −3.9% net margin × 0.78× asset turns × 1.93× balance-sheet leverage ≈ −5.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 1.7% − 9.7% = a −8.0 pp spread. The 9.7% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Methode Electronics, Inc. paid $0.22 per share over the last four reported quarters, down 64.3% on a year ago. The most recent declaration was $0.05 for May 26. Against the current price of $15.1 that is a trailing yield of 1.46%, measured on dividends already paid rather than on a forecast.
Methode Electronics, Inc. paid $0.22 per share across the last four reported quarters, most recently $0.05 for May 26. That is down 64.3% against the same quarter a year earlier. Against the current price of $15.1 the trailing twelve months work out to 1.46% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Methode Electronics, Inc. carries total debt of $0.3 B against shareholder equity of $0.7 B as of May 26, a debt-to-equity of 0.51. On the annual view that ratio went from 0.25 in FY22 to 0.51 in FY26. Read the returns elsewhere on this page with that leverage in mind.
May 26: total debt of $0.3 B against shareholder equity of $0.7 B — a debt-to-equity of 0.51. On the annual view, debt-to-equity went from 0.25 (FY22) to 0.51 (FY26). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
6.8% of Methode Electronics, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.2 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 6.8% of the float is sold short, and at typical trading volumes it would take about 2.2 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Methode Electronics, Inc.: the Z-score reads 1.90. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 1.90 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 1.90.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Jabil Inc.JBL | 58.5/100Mixed-positive evidence81% evidence | ASLEEP | 22.1/35 Revenue 17.8% · PAT 49.2% · OPM change 0 pp 83% evidence | 14.3/25 ROCE 9% · OPM 5.1% 76% evidence | 14.6/20 P/E 45.5× · PEG 0.82 65% evidence | 7.5/20 RS sector -10% · RS bench 15% · 1Y 51.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 14.3 + 14.6 + 7.5 = 58.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Amphenol CorporationAPH | 57.3/100Thin evidence · provisional56% evidence | TURNING | 20.3/35 Revenue — · PAT — · OPM change 2.7 pp 39% evidence | 17.4/25 ROCE 9.3% · OPM 24% 76% evidence | 9.9/20 P/E 44.2× · PEG — 15% evidence | 9.7/20 RS sector -14.7% · RS bench 11.7% · 1Y 55.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.3 + 17.4 + 9.9 + 9.7 = 57.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3CTS CorporationCTS | 55.9/100Thin evidence · provisional56% evidence | TURNING | 19.4/35 Revenue — · PAT — · OPM change 2.9 pp 39% evidence | 14.2/25 ROCE 3.9% · OPM 15.8% 76% evidence | 10.7/20 P/E 27.4× · PEG — 15% evidence | 11.6/20 RS sector -6.8% · RS bench 20% · 1Y 71.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 14.2 + 10.7 + 11.6 = 55.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Methode Electronics, Inc.this pageMEI | 55.2/100Mixed-positive evidence64% evidence | LEADER | 19.0/35 Revenue -2.8% · PAT — · OPM change 12.9 pp 62% evidence | 5.2/25 ROCE 1% · OPM 3.7% 76% evidence | 11.2/20 P/E 21.4× · PEG — 15% evidence | 19.8/20 RS sector 20.9% · RS bench 53.4% · 1Y 133%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 5.2 + 11.2 + 19.8 = 55.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Allient Inc.ALNT | 55.0/100Thin evidence · provisional60% evidence | BREAKING OUT | 18.6/35 Revenue 8.7% · PAT 100% · OPM change 0.1 pp 53% evidence | 10.1/25 ROCE 1.8% · OPM 6.7% 57% evidence | 11.3/20 P/E 41.3× · PEG 1.47 65% evidence | 15.0/20 RS sector 4.6% · RS bench 33.1% · 1Y 125.1%11 of 12 weeks ahead 70% evidence |
| Exact sum: 18.6 + 10.1 + 11.3 + 15 = 55 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Knowles CorporationKN | 54.9/100Thin evidence · provisional56% evidence | LEADER | 20.1/35 Revenue — · PAT — · OPM change 7.4 pp 39% evidence | 9.1/25 ROCE 2.6% · OPM 10.4% 76% evidence | 9.5/20 P/E 53.9× · PEG — 15% evidence | 16.2/20 RS sector 3.1% · RS bench 31.5% · 1Y 102.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 9.1 + 9.5 + 16.2 = 54.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Celestica Inc.CLS | 54.1/100Thin evidence · provisional56% evidence | ASLEEP | 21.7/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence | 16.6/25 ROCE 14% · OPM 6.7% 76% evidence | 10.5/20 P/E 37.9× · PEG — 15% evidence | 5.3/20 RS sector -15.9% · RS bench 8.9% · 1Y 78.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 16.6 + 10.5 + 5.3 = 54.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8M-tron Industries, Inc.MPTI | 53.2/100Thin evidence · provisional60% evidence | FADING | 14.7/35 Revenue 9.8% · PAT 12.5% · OPM change 2 pp 53% evidence | 13.6/25 ROCE 4.9% · OPM 17.8% 57% evidence | 14.2/20 P/E 25.9× · PEG 0.98 65% evidence | 10.7/20 RS sector -3.4% · RS bench 23% · 1Y 102.9%11 of 12 weeks ahead 70% evidence |
| Exact sum: 14.7 + 13.6 + 14.2 + 10.7 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Littelfuse, Inc.LFUS | 52.6/100Thin evidence · provisional56% evidence | ASLEEP | 19.2/35 Revenue — · PAT — · OPM change 2.7 pp 39% evidence | 12.0/25 ROCE 3.4% · OPM 15.4% 76% evidence | 9.4/20 P/E 54.9× · PEG — 15% evidence | 12.0/20 RS sector -1% · RS bench 25.8% · 1Y 87.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 12 + 9.4 + 12 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Plexus Corp.PLXS | 51.9/100Thin evidence · provisional56% evidence | FADING | 16.6/35 Revenue — · PAT — · OPM change 0 pp 39% evidence | 11.7/25 ROCE 3.7% · OPM 5.3% 76% evidence | 10.3/20 P/E 40.6× · PEG — 15% evidence | 13.3/20 RS sector 0.9% · RS bench 27.2% · 1Y 113.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.7 + 10.3 + 13.3 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Vicor CorporationVICR | 51.4/100Thin evidence · provisional56% evidence | FADING | 16.9/35 Revenue — · PAT — · OPM change 15.1 pp 39% evidence | 13.7/25 ROCE 4.8% · OPM 14.9% 76% evidence | 8.7/20 P/E 121.7× · PEG — 15% evidence | 12.1/20 RS sector 8% · RS bench 28.5% · 1Y 383.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 13.7 + 8.7 + 12.1 = 51.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Flex Ltd.FLEX | 51.1/100Thin evidence · provisional56% evidence | FADING | 16.6/35 Revenue — · PAT — · OPM change 0.2 pp 39% evidence | 11.4/25 ROCE 3.7% · OPM 5% 76% evidence | 9.3/20 P/E 56.6× · PEG — 15% evidence | 13.8/20 RS sector 12.2% · RS bench 39.2% · 1Y 151.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.4 + 9.3 + 13.8 = 51.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Benchmark Electronics, Inc.BHE | 50.8/100Thin evidence · provisional56% evidence | FADING | 18.4/35 Revenue — · PAT — · OPM change 1.3 pp 39% evidence | 9.1/25 ROCE 2.1% · OPM 3.2% 76% evidence | 9.2/20 P/E 67.1× · PEG — 15% evidence | 14.1/20 RS sector 5.3% · RS bench 31.9% · 1Y 122.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 9.1 + 9.2 + 14.1 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14TE Connectivity plcTEL | 50.4/100Thin evidence · provisional56% evidence | TURNING | 18.0/35 Revenue — · PAT — · OPM change 2 pp 39% evidence | 15.6/25 ROCE 4.8% · OPM 20.1% 76% evidence | 11.5/20 P/E 19× · PEG — 15% evidence | 5.3/20 RS sector -33.3% · RS bench -10.8% · 1Y 7.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 15.6 + 11.5 + 5.3 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Daktronics, Inc.DAKT | 48.4/100Thin evidence · provisional58% evidence | TURNING | 22.7/35 Revenue 10.8% · PAT — · OPM change 7.8 pp 62% evidence | 10.6/25 ROCE 4.1% · OPM 6.8% 76% evidence | 11.1/20 P/E 21.4× · PEG — 15% evidence | 4.0/20 RS sector -28% · RS bench -4.7% · 1Y 26.6%0 of 12 weeks ahead 70% evidence |
| Exact sum: 22.7 + 10.6 + 11.1 + 4 = 48.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Sanmina CorporationSANM | 47.9/100Thin evidence · provisional56% evidence | FADING | 18.7/35 Revenue — · PAT — · OPM change -0.7 pp 39% evidence | 13.3/25 ROCE 5.3% · OPM 3.9% 76% evidence | 10.1/20 P/E 42.3× · PEG — 15% evidence | 5.8/20 RS sector -11.6% · RS bench 12.6% · 1Y 71.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 13.3 + 10.1 + 5.8 = 47.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17TTM Technologies, Inc.TTMI | 47.3/100Mixed-negative evidence66% evidence | FADING | 20.5/35 Revenue 25.4% · PAT 84.9% · OPM change 0.9 pp 53% evidence | 10.1/25 ROCE 2.6% · OPM 8.6% 57% evidence | 8.8/20 P/E 47.7× · PEG 1.82 65% evidence | 7.9/20 RS sector -2.3% · RS bench 18.8% · 1Y 193.3%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 10.1 + 8.8 + 7.9 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bel Fuse Inc.BELFA | 46.6/100Thin evidence · provisional56% evidence | ASLEEP | 15.9/35 Revenue — · PAT — · OPM change -3.1 pp 39% evidence | 13.8/25 ROCE 4% · OPM 13.3% 76% evidence | 9.1/20 P/E 74.5× · PEG — 15% evidence | 7.8/20 RS sector -4.9% · RS bench 19.6% · 1Y 109.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 13.8 + 9.1 + 7.8 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Universal Display CorporationOLED | 44.4/100Thin evidence · provisional56% evidence | BASING | 14.1/35 Revenue — · PAT — · OPM change -11.8 pp 39% evidence | 13.7/25 ROCE 3% · OPM 30.1% 76% evidence | 11.3/20 P/E 21× · PEG — 15% evidence | 5.3/20 RS sector -50% · RS bench -31.1% · 1Y -37.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 13.7 + 11.3 + 5.3 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Corning IncorporatedGLW | 44.3/100Thin evidence · provisional56% evidence | ASLEEP | 17.9/35 Revenue — · PAT — · OPM change 2.5 pp 39% evidence | 11.1/25 ROCE 2.8% · OPM 15.4% 76% evidence | 8.8/20 P/E 116.6× · PEG — 15% evidence | 6.5/20 RS sector -5.8% · RS bench 16.8% · 1Y 143.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 11.1 + 8.8 + 6.5 = 44.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Rogers CorporationROG | 44.2/100Thin evidence · provisional56% evidence | FADING | 22.2/35 Revenue — · PAT — · OPM change 5.5 pp 39% evidence | 7.0/25 ROCE 1.5% · OPM 5.3% 76% evidence | 8.9/20 P/E 93.6× · PEG — 15% evidence | 6.1/20 RS sector -12.2% · RS bench 11.8% · 1Y 88.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 7 + 8.9 + 6.1 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22LSI Industries Inc.LYTS | 36.5/100Thin evidence · provisional60% evidence | FADING | 15.1/35 Revenue 11.5% · PAT 17.4% · OPM change -2 pp 53% evidence | 8.8/25 ROCE 0.9% · OPM 2.7% 57% evidence | 6.8/20 P/E 24.8× · PEG 3.44 65% evidence | 5.8/20 RS sector -22.7% · RS bench 1.9% · 1Y 34.8%6 of 12 weeks ahead 70% evidence |
| Exact sum: 15.1 + 8.8 + 6.8 + 5.8 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Kopin CorporationKOPN | 36.5/100Thin evidence · provisional51% evidence | FADING | 15.4/35 Revenue -23.5% · PAT — · OPM change -19.6 pp 40% evidence | 5.5/25 ROCE -12.6% · OPM -56.7% 57% evidence | 8.5/20 P/E 181.5× · PEG — 15% evidence | 7.1/20 RS sector -5.4% · RS bench 20.3% · 1Y 116.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 5.5 + 8.5 + 7.1 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24OSI Systems, Inc.OSIS | 35.6/100Mixed-negative evidence66% evidence | BASING | 12.6/35 Revenue 7% · PAT 7.8% · OPM change -1 pp 53% evidence | 12.2/25 ROCE 3% · OPM 11.7% 57% evidence | 5.6/20 P/E 30.3× · PEG 4.61 65% evidence | 5.2/20 RS sector -37.2% · RS bench -16% · 1Y 4.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 12.2 + 5.6 + 5.2 = 35.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Ouster, Inc.OUST | 57.2/100Thin evidence · provisional48% evidence | LEADER | 22.1/35 Revenue 57.6% · PAT — · OPM change 33.5 pp 40% evidence | 5.7/25 ROCE -8% · OPM -39.5% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 19.4/20 RS sector 14.5% · RS bench 48.9% · 1Y 85.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 5.7 + 10 + 19.4 = 57.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Richardson Electronics, Ltd.RELL | 50.1/100Thin evidence · provisional50% evidence | LEADER | 16.4/35 Revenue — · PAT — · OPM change -1.3 pp 39% evidence | 6.6/25 ROCE 1.9% · OPM 2.7% 76% evidence | 10.4/20 P/E 38.6× · PEG — 15% evidence | 16.7/20 RS sector 18.2% · RS bench 50.7% · 1Y 122.9%12 of 12 weeks ahead 70% evidence |
| Exact sum: 16.4 + 6.6 + 10.4 + 16.7 = 50.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Ralliant CorporationRAL | 48.2/100Thin evidence · provisional50% evidence | LEADER | 18.1/35 Revenue — · PAT — · OPM change 1 pp 39% evidence | 10.0/25 ROCE 2.1% · OPM 12.7% 76% evidence | 11.4/20 P/E 20.8× · PEG — 15% evidence | 8.7/20 RS sector -8.5% · RS bench 18.8% · 1Y 48.7%12 of 12 weeks ahead 70% evidence |
| Exact sum: 18.1 + 10 + 11.4 + 8.7 = 48.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28FabrinetFN | 45.0/100Thin evidence · provisional46% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change 0.6 pp 24% evidence | 14.2/25 ROCE 5.6% · OPM 10.1% 57% evidence | 9.7/20 P/E 47× · PEG — 15% evidence | 2.8/20 RS sector -24.8% · RS bench -3.5% · 1Y 54.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 14.2 + 9.7 + 2.8 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29LightPath Technologies, Inc.LPTH | 44.7/100Thin evidence · provisional42% evidence | TURNING | 21.5/35 Revenue 87.9% · PAT — · OPM change 15.5 pp 40% evidence | 6.1/25 ROCE -4.4% · OPM -22.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.1/20 RS sector -13.1% · RS bench 9.3% · 1Y 244.1%7 of 12 weeks ahead 70% evidence |
| Exact sum: 21.5 + 6.1 + 10 + 7.1 = 44.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30Syntec Optics Holdings, Inc.OPTX | 41.4/100Thin evidence · provisional45% evidence | TURNING | 11.2/35 Revenue 0% · PAT — · OPM change -19.4 pp 40% evidence | 6.2/25 ROCE -5.6% · OPM -11.9% 57% evidence | 8.6/20 P/E 123× · PEG — 15% evidence | 15.4/20 RS sector 11.6% · RS bench 30.4% · 1Y 388.9%7 of 12 weeks ahead 70% evidence |
| Exact sum: 11.2 + 6.2 + 8.6 + 15.4 = 41.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Methode Electronics, Inc.'s stock price today?
Methode Electronics, Inc. trades at $15.1, +138.5% over the past year. The company is valued at $1.0 B. The stock sits at 71% of its 52-week range of $5–$19, +65.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 9 weeks in. — as of 5 August 2026.
What were Methode Electronics, Inc.'s latest quarterly results?
Methode Electronics, Inc. reported revenue of $0.3 B and net profit of $0.0 B for the May 26 quarter. Earnings per share were $0.01. The operating margin was 3.3%, 11.0 pp higher than a year earlier. — as of 5 August 2026.
What is Methode Electronics, Inc.'s revenue?
Methode Electronics, Inc. reported revenue of $0.3 B in the May 26 quarter, +15.4% year on year. For the full FY26 fiscal year, revenue was $1.0 B (−2.9%). Over the last 4 years revenue compounded at −3.2% a year. — as of 5 August 2026.
What is Methode Electronics, Inc.'s profit?
Methode Electronics, Inc. earned $0.0 B of net profit in the May 26 quarter. Full-year FY26 profit was $−0.0 B. The operating margin ran 3.3% in the latest quarter. — as of 5 August 2026.
What is Methode Electronics, Inc.'s market cap?
Methode Electronics, Inc.'s market capitalisation is $1.0 B at a stock price of $15.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Methode Electronics, Inc.'s P/E ratio?
Methode Electronics, Inc. trades at a P/E of 14.1×, at the 15th percentile of its own 2-year range, against a long-run median of 16.1×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Methode Electronics, Inc. pay a dividend?
Yes — Methode Electronics, Inc. declared $0.05 per share for May 26, and $0.22 per share across the last four reported quarters. The latest quarter is down 64.3% on the same quarter a year earlier. — as of 5 August 2026.
What is Methode Electronics, Inc.'s dividend per share?
Methode Electronics, Inc.'s most recently declared dividend is $0.05 per share for May 26, giving $0.22 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is Methode Electronics, Inc.'s dividend yield?
Methode Electronics, Inc.'s trailing dividend yield is 1.46%: $0.22 declared per share across the last four reported quarters, against a share price of $15.1. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is Methode Electronics, Inc. overvalued?
On its own history, Methode Electronics, Inc. looks cheap against its own history: its P/E of 14.1× has been cheaper only 15% of the time in 2 years (long-run median 16.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
How is Methode Electronics, Inc. performing?
Methode Electronics, Inc. is in a confirmed uptrend, 9 weeks in. Against the S&P 500 it has been ahead on a trailing-13-week view for 13 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is Methode Electronics, Inc. in an uptrend?
Yes — the price is in a confirmed uptrend (week 9 of stage 2), trading +65.0% versus its 200-day average and at 71% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Methode Electronics, Inc. beating the market?
On recent form, yes — Methode Electronics, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 13 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved −56% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will Methode Electronics, Inc.'s stock price go up?
This page publishes no price forecast for Methode Electronics, Inc. What it measures instead: the stock price is $15.1, the price is in a confirmed uptrend 9 weeks in. Its P/E of 14.1× sits at the 15th percentile of its own 2-year range. — as of 5 August 2026.
Is the market betting against Methode Electronics, Inc.?
Somewhat — short interest is 6.8% of Methode Electronics, Inc.'s tradable float, about 2.2 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Methode Electronics, Inc. have too much debt?
It is moderate — Methode Electronics, Inc.'s debt-to-equity is 0.52. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Methode Electronics, Inc.'s capex?
Methode Electronics, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.0 B. — as of 5 August 2026.
What is Methode Electronics, Inc.'s cash flow?
Methode Electronics, Inc. generated $0.0 B of operating cash flow in FY26 and $0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Methode Electronics, Inc.'s profit real cash?
Yes — over the last 2 fiscal years, 128% of Methode Electronics, Inc.'s reported profit arrived as operating cash. In FY26, operating cash was $0.0 B against reported profit of $−0.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Methode Electronics, Inc.?
On the balance sheet, the Z-score reads 1.90 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.
Where is Methode Electronics, Inc. in its business cycle?
Methode Electronics, Inc.'s FY26 operating margin was 1.0%, against a 5-year band of −9.9%–9.5%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 3.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Methode Electronics, Inc. story?
Biggest watch item: the price is already 9 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Methode Electronics, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Methode Electronics, Inc. is coiled. The quarters are improving, yet the P/E sits at the 15th percentile of its own 2-year range — the business is moving before the market. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.